Guruprasad P. Aithal
NIHR Nottingham Digestive Diseases Biomedical Research Unit(GB)Queen's Medical Centre(GB)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Drug-Induced Hepatotoxicity and Protection, Pharmacogenetics and Drug Metabolism, Hepatitis C virus research
Most-Cited Works
- → Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study(2015)2,058 cited
- → Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications(1999)1,244 cited
- → Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial(2019)1,186 cited
- → EASL Clinical Practice Guidelines: Drug-induced liver injury(2019)1,078 cited
- → HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin(2009)1,037 cited
- → Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening